ACAD
36.73
-0.26
-0.70%
AEMD
0.98
+0.01
+1.03%
APRI
1.9
+0.11
+6.15%
ARNA
27.56
+0.71
+2.64%
ATEC
4.13
+0.36
+9.55%
CNAT
5.15
+0.05
+0.98%
CRXM
0.137
-0.018
-11.71613%
CYTX
0.486
+0.016
+3.470%
DXCM
44.95
-0.04
-0.09%
GNMK
8.06
-0.05
-0.62%
HALO
17.72
-0.02
-0.11%
ILMN
205.62
-0.86
-0.42%
INNV
0.09
+0.003
+3.6994%
INO
6.32
+0.08
+1.28%
ISCO
1.51
-0.16
-9.58%
ISIS
57.56
0.00
0.00%
LGND
144.16
+2.01
+1.41%
LPTN
2.93
-2.93
-100.00%
MBVX
0.715
-0.015
-2.082%
MEIP
2.48
+0.15
+6.44%
MNOV
6.38
-0.24
-3.63%
MRTX
14.35
+0.1
+0.70%
MSTX
0.13
-0.01
0.00%
NBIX
59.42
-1.45
-2.38%
NUVA
54.18
+0.47
+0.88%
ONCS
1.28
+0.07
+5.79%
ONVO
1.48
-0.04
-2.63%
OREX
1.87
-0.02
-1.06%
OTIC
3.45
-0.02
-0.72%
QDEL
41.71
+0.35
+0.85%
RCPT
231.96
0.00
0.00%
RGLS
1.32
0.00
0.00%
RMD
78.87
+0.45
+0.57%
SCIE
0
0.00
0.00%
SPHS
2.243
-0.037
-1.6272%
SRNE
2.6
-0.25
-8.77%
TROV
0.868
+0.078
+9.873%
VICL
2.38
-0.15
-5.93%
VOLC
18
0.00
0.00%
ZGNX
39
+0.9
+2.36%
ACAD
36.73
-0.26
-0.70%
AEMD
0.98
+0.01
+1.03%
APRI
1.9
+0.11
+6.15%
ARNA
27.56
+0.71
+2.64%
ATEC
4.13
+0.36
+9.55%
CNAT
5.15
+0.05
+0.98%
CRXM
0.137
-0.018
-11.71613%
CYTX
0.486
+0.016
+3.470%
DXCM
44.95
-0.04
-0.09%
GNMK
8.06
-0.05
-0.62%
HALO
17.72
-0.02
-0.11%
ILMN
205.62
-0.86
-0.42%
INNV
0.09
+0.003
+3.6994%
INO
6.32
+0.08
+1.28%
ISCO
1.51
-0.16
-9.58%
ISIS
57.56
0.00
0.00%
LGND
144.16
+2.01
+1.41%
LPTN
2.93
-2.93
-100.00%
MBVX
0.715
-0.015
-2.082%
MEIP
2.48
+0.15
+6.44%
MNOV
6.38
-0.24
-3.63%
MRTX
14.35
+0.1
+0.70%
MSTX
0.13
-0.01
0.00%
NBIX
59.42
-1.45
-2.38%
NUVA
54.18
+0.47
+0.88%
ONCS
1.28
+0.07
+5.79%
ONVO
1.48
-0.04
-2.63%
OREX
1.87
-0.02
-1.06%
OTIC
3.45
-0.02
-0.72%
QDEL
41.71
+0.35
+0.85%
RCPT
231.96
0.00
0.00%
RGLS
1.32
0.00
0.00%
RMD
78.87
+0.45
+0.57%
SCIE
0
0.00
0.00%
SPHS
2.243
-0.037
-1.6272%
SRNE
2.6
-0.25
-8.77%
TROV
0.868
+0.078
+9.873%
VICL
2.38
-0.15
-5.93%
VOLC
18
0.00
0.00%
ZGNX
39
+0.9
+2.36%
Home » Archive by Category

Xconomy

Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists

August 28, 2017 – 4:00 am

It’s clear at this point that patients are no longer just subjects in clinical trials. Thanks to the growing power of patient advocacy groups—and an FDA eager to hear their…

[[Click headline to continue reading.]]

Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand

August 25, 2017 – 3:00 am

In these politically divided times, Americans this week found near universal agreement on one thing: A celestial event that plunges a summer day into temporary darkness is a captivating experience….

[[Click headline to continue reading.]]

Stand Up to “Bully” Trump: Bio CEOs Levin, Holtzman Call to Their Peers

August 24, 2017 – 2:55 am

Biotech CEOs Jeremy Levin and Steve Holtzman have watched the violence in Charlottesville, VA, and its continuing aftermath with disgust. But they aren’t just upset about the rally, the…

[[Click headline to continue reading.]]

On Drug Pricing: FDA Backs Up Its Calls for Increased Competition

August 21, 2017 – 4:40 am

FDA Commissioner Scott Gottlieb has been very public in expressing his desire to provide increased competition and greater choice to American consumers in a bid to drive down prices of prescription…

[[Click headline to continue reading.]]

Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More

August 18, 2017 – 3:45 am

The CEO of a major U.S. pharmaceutical company was in the news this week, but for a change not because of the cost of drugs. Merck CEO Kenneth Frazier (pictured) was the first of what quickly became…

[[Click headline to continue reading.]]

Expanding Tissue and Squeezing Cells: Meet Xconomy’s Young Innovator Award Finalists

August 17, 2017 – 8:17 am

The finalists in the Young Innovator category of the 2017 Xconomy Awards show that it’s never too early in life to start a company or invent a new technology. These four individuals (30 years of age…

[[Click headline to continue reading.]]

Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists

August 14, 2017 – 5:30 am

Startups play a critical role in the innovation economy that we chronicle at Xconomy—transforming new ideas that begin in a lab into the products and companies of tomorrow. No surprise, then,…

[[Click headline to continue reading.]]

GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up

August 11, 2017 – 4:33 am

A race is on to bring two new RNA-based drugs for a rare, debilitating nerve disease called familial amyloid polyneuropathy (FAP). And GlaxoSmithKline has just dropped out of it. This morning, Ionis…

[[Click headline to continue reading.]]

Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More

August 11, 2017 – 2:55 am

With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences…

[[Click headline to continue reading.]]

Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists

August 10, 2017 – 2:00 am

There are many ways to stand out as a biotech CEO, from getting a company started in the first place to pushing its first drug over the finish line. Those differences are what we noticed when going…

[[Click headline to continue reading.]]